{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:19:52Z","timestamp":1792271992331,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007470","name":"Shaqra University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijbiomac.2024.130146","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:15:02Z","timestamp":1707974102000},"page":"130146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P2","title":["Exploring the promising potential of noscapine for cancer and neurodegenerative disease therapy through inhibition of integrin-linked kinase-1"],"prefix":"10.1016","volume":"262","author":[{"given":"Mohammed Ageeli","family":"Hakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader S.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia S.","family":"Alkhalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleha","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeba Shamim","family":"Jairajpuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hazazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishal Olayan","family":"Alsulami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Jawaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmendra Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan H.","family":"Almasoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ijbiomac.2024.130146_bb0005","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.00-0029com","article-title":"Na+\/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes","volume":"14","author":"Reshkin","year":"2000","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130146_bb0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1242\/jcs.195297","article-title":"Cancer cell behaviors mediated by dysregulated pH dynamics at a glance","volume":"130","author":"White","year":"2017","journal-title":"J. Cell Sci."},{"issue":"31","key":"10.1016\/j.ijbiomac.2024.130146_bb0015","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1038\/s41388-022-02396-6","article-title":"Alkalization of cellular pH leads to cancer cell death by disrupting autophagy and mitochondrial function","volume":"41","author":"Ying","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0020","doi-asserted-by":"crossref","first-page":"8911","DOI":"10.1038\/s41598-017-09426-4","article-title":"Chemotherapy with cisplatin: insights into intracellular pH and metabolic landscape of cancer cells in vitro and in vivo","volume":"7","author":"Shirmanova","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130146_bb0025","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3892\/ijo.2015.2884","article-title":"Bleb formation is induced by alkaline but not acidic pH in estrogen receptor silenced breast cancer cells","volume":"46","author":"Khajah","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.130146_bb0030","doi-asserted-by":"crossref","first-page":"21091","DOI":"10.18632\/oncotarget.8520","article-title":"Na+\/H+ exchanger NHE1 regulation modulates metastatic potential and epithelial-mesenchymal transition of triple-negative breast cancer cells","volume":"7","author":"Amith","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0035","article-title":"Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy","volume":"1876","author":"Anwar","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130146_bb0040","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI76094","article-title":"Targeting cancer with kinase inhibitors","volume":"125","author":"Gross","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130146_bb0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200108077","article-title":"Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes","volume":"155","author":"Wu","year":"2001","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1573408052952694","article-title":"Role of integrin-linked kinase in neuronal cells","volume":"1","author":"Ishii","year":"2005","journal-title":"Curr. Enzym. Inhib."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.130146_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/brainsci8090177","article-title":"Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches","volume":"8","author":"Hussain","year":"2018","journal-title":"Brain Sci."},{"issue":"102113","key":"10.1016\/j.ijbiomac.2024.130146_bb0060","first-page":"31","article-title":"Recent advancement in therapeutic strategies for Alzheimer\u2019s disease: insights from clinical trials","volume":"92","author":"Khan","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"43","key":"10.1016\/j.ijbiomac.2024.130146_bb0065","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1038\/onc.2011.177","article-title":"Integrin-linked kinase: not so \u2018pseudo\u2019 after all","volume":"30","author":"Hannigan","year":"2011","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.130146_bb0070","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/01.RES.0000265233.40455.62","article-title":"Integrin-linked kinase at the heart of cardiac contractility, repair, and disease","volume":"100","author":"Hannigan","year":"2007","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130146_bb0075","first-page":"563","article-title":"Integrin-linked kinase and associated proteins","volume":"3","author":"Huang","year":"1999","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1023777013659","article-title":"The role of integrin-linked kinase (ILK) in cancer progression","volume":"22","author":"Persad","year":"2003","journal-title":"Cancer Metastasis Rev."},{"issue":"52","key":"10.1016\/j.ijbiomac.2024.130146_bb0085","doi-asserted-by":"crossref","first-page":"20677","DOI":"10.1073\/pnas.0811415106","article-title":"The structural basis of integrin-linked kinase\u2013PINCH interactions","volume":"105","author":"Chiswell","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1074\/jbc.M108257200","article-title":"A critical role of the PINCH-integrin-linked kinase interaction in the regulation of cell shape change and migration","volume":"277","author":"Zhang","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.ijbiomac.2024.130146_bb0095","doi-asserted-by":"crossref","first-page":"23499","DOI":"10.1074\/jbc.M102163200","article-title":"Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions","volume":"276","author":"Nikolopoulos","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0100","first-page":"186","article-title":"Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer","volume":"9","author":"Zheng","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.130146_bb0105","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.yexcr.2013.05.014","article-title":"Small interfering RNA targeting ILK inhibits metastasis in human tongue cancer cells through repression of epithelial-to-mesenchymal transition","volume":"319","author":"Xing","year":"2013","journal-title":"Exp. Cell Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130146_bb0110","doi-asserted-by":"crossref","first-page":"995","DOI":"10.7150\/ijms.5963","article-title":"Overexpression of integrin-linked kinase promotes lung cancer cell migration and invasion via NF-\u03baB-mediated upregulation of matrix metalloproteinase-9","volume":"10","author":"Zhao","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10735-013-9540-5","article-title":"Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-\u03baB pathway","volume":"45","author":"Liang","year":"2014","journal-title":"J. Mol. Histol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.130146_bb0120","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.3748\/wjg.v22.i15.3969","article-title":"Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-\u03baB signaling in colorectal cancer cells","volume":"22","author":"Shen","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130146_bb0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.acthis.2013.11.001","article-title":"Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial\u2013mesenchymal transition via NF-\u03baB signaling","volume":"116","author":"Yan","year":"2014","journal-title":"Acta Histochem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130146_bb0130","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1080\/07391102.2017.1344141","article-title":"Identification of potential inhibitors of Fasciola gigantica thioredoxin1: computa- tional screening, molecular dynamics simulation, and binding free energy studies","volume":"36","author":"Shukla","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130146_bb0135","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1080\/07391102.2017.1341337","article-title":"Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of mycobacterium tuberculosis isocitrate lyase","volume":"36","author":"Shukla","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130146_bb0140","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/med.21357","article-title":"The noscapine chronicle: a pharmaco-historic biography of the opiate alkaloid family and its clinical applications","volume":"35","author":"Rida","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00315110","article-title":"Pharmacokinetics of oral noscapine","volume":"39","author":"Karlsson","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0150","first-page":"525","article-title":"Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis","author":"Sebak","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0155","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00280-007-0430-y","article-title":"Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anti-cancer agent","volume":"60","author":"Aneja","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130146_bb0160","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/0008-5472.CAN-09-4230","article-title":"Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-\u03baB signaling pathway","volume":"70","author":"Sung","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10822-011-9508-z","article-title":"In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin)","volume":"26","author":"Naik","year":"2012","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.130146_bb0170","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1080\/14786419.2022.2055014","article-title":"Comparative metabolic profiling, isolation of alkylated phenols and antioxidant activity of roots of Plumbago species using GC-MS and NMR based metabolomics study","volume":"36","author":"Tripathi","year":"2022","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijbiomac.2017.12.164","article-title":"Mechanistic insights into the urea-induced denaturation of kinase domain of human integrin linked kinase","volume":"111","author":"Syed","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0180","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.ijbiomac.2018.06.025","article-title":"Unravelling the unfolding mechanism of human integrin linked kinase by GdmCl-induced denaturation","volume":"117","author":"Syed","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/07391102.2017.1420492","article-title":"Estimation of pH effect on the structure and stability of kinase domain of human integrin-linked kinase","volume":"37","author":"Syed","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130146_bb0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/biom10050789","article-title":"MARK4 inhibited by AChE inhibitors, donepezil and Rivastigmine tartrate: insights into Alzheimer\u2019s disease therapy","volume":"10","author":"Shamsi","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0195","doi-asserted-by":"crossref","first-page":"10300","DOI":"10.1038\/s41598-020-65648-z","article-title":"Rosmarinic acid exhibits anti-cancer effects via MARK4 inhibition","volume":"10","author":"Anwar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109245","article-title":"Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: a targeted approach towards anti-cancer therapy","volume":"118","author":"Gupta","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0205","doi-asserted-by":"crossref","unstructured":"NS. Khan, P. Khan, M.F. Ansari, S. Srivastava, G.M. Hasan, M. Husain, M.I. Hassan, Thienopyrimidine\u2013chalcone hybrid molecules inhibit fas-activated serine\/threonine kinase: an approach to ameliorate antiproliferation in human breast cancer cells, Mol. Pharm. 15(9) (2018) 4173\u20134189.","DOI":"10.1021\/acs.molpharmaceut.8b00566"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130146_bb0210","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/07391102.2019.1595728","article-title":"Spectros- copic, calorimetric and molecular docking insight into the interaction of Alzheimer\u2019s drug donepezil with human transferrin: implications of Alzheimer\u2019s drug","volume":"38","author":"Shamsi","year":"2020","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.130146_bb0215","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1080\/07391102.2018.1546621","article-title":"Binding mechanism of caffeic acid and simvastatin to the integrin linked kinase for therapeutic implications: a comparative docking and MD simulation studies","volume":"37","author":"Gulzar","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0220","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ijbiomac.2018.09.089","article-title":"Elucidation of interaction mechanism of ellagic acid to the integrin linked kinase","volume":"122","author":"Gulzar","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0225","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2094635","article-title":"Identification of potential inhibitors of calcium\/calmodulin-dependent protein kinase IV from bioactive phytoconstituents","volume":"2020","author":"Gupta","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"NPJ Precision Oncology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130146_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa279","article-title":"InstaDock: a single-click graphical user interface for molecular docking-based virtual high-throughput screening","volume":"22","author":"Mohammad","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0240","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsl. Protein Crystallogr"},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0245","series-title":"Discovery Studio Visualizer, San Diego, CA, USA","volume":"vol. 936","author":"Biovia","year":"2017"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130146_bb0250","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jcb.30176","article-title":"Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4","volume":"123","author":"Anwar","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125364","article-title":"Investigating MARK4 inhibitory potential of Bacopaside II: targeting Alzheimer\u2019s disease","volume":"245","author":"Anwar","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0260","series-title":"Structure and Dynamics of Macromolecules: Absorption and Fluorescence Studies","author":"Albani","year":"2011"},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0265","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2018.09.030","article-title":"Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors","volume":"159","author":"Parveen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0270","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s10895-011-0922-3","article-title":"Study of interaction of silver nanoparticles with bovine serum albumin using fluorescence spectroscopy","volume":"21","author":"Mariam","year":"2011","journal-title":"J. Fluoresc."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2024.130146_bb0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.molstruc.2011.05.023","article-title":"Fluorescence quenching and ligand binding: a critical discussion of a popular methodology","volume":"998","author":"Van de Weert","year":"2011","journal-title":"J. Mol. Struct."},{"issue":"19","key":"10.1016\/j.ijbiomac.2024.130146_bb0280","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1021\/jp2008978","article-title":"Exploring the mechanism of fluorescence quenching in proteins induced by tetracycline","volume":"115","author":"Anand","year":"2011","journal-title":"J. Phys. Chem. B."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130146_bb0285","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/biom10050789","article-title":"MARK4 inhibited by AChE inhibitors, donepezil and Rivastigmine tartrate: insights into Alzheimer\u2019s disease therapy","volume":"10","author":"Shamsi","year":"2020","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.130146_bb0290","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1080\/07391102.2020.1858964","article-title":"Insight into the binding of PEG-400 with eye protein alpha-crystallin: multi spectroscopic and computational approach: possible therapeutics targeting eye diseases","volume":"40","author":"Shamsi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130146_bb0295","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.foodchem.2013.05.026","article-title":"Interaction of anthocyanins with human serum albumin: influence of pH and chemical structure on binding","volume":"141","author":"Cahyana","year":"2013","journal-title":"Food Chem."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.130146_bb0300","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2174\/138161212799958486","article-title":"Experimental methods for studying the interactions between G-quadruplex structures and ligands","volume":"18","author":"Jaumot","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130146_bb0305","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.biochi.2011.06.007","article-title":"A stabilizing and denaturing dual-effect for natural polyamines interacting with G-quadruplexes depending on concentration","volume":"93","author":"Sun","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0310","first-page":"203","article-title":"Recent advances in molecular luminescence analysis","author":"Miller","year":"1979","journal-title":"Proc. Anal. Div. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0031-6997(25)06849-8","article-title":"Molecular aspects of ligand binding to serum albumin","volume":"33","author":"Kragh-Hansen","year":"1981","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.130146_bb0320","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2174\/1568026616999150918145640","article-title":"Editorial (thematic issue: recent advances in the structure-based drug design and discovery)","volume":"16","author":"Hassan","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130146_bb0325","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/acs.jnatprod.9b00105","article-title":"Microtubule-targeting drugs: more than antimitotics","volume":"82","author":"Kaul","year":"2019","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130146_bb0330","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1021\/acs.jnatprod.8b00959","article-title":"Natural products from the Yucatecan flora: structural diversity and biological activity","volume":"82","author":"Hern\u00e1ndez-Bolio","year":"2019","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12013-013-9550-7","article-title":"Microtubule affinity-regulating kinase 4: structure, function, and regulation","volume":"67","author":"Naz","year":"2013","journal-title":"Cell Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0345","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pbiomolbio.2015.12.016","article-title":"Calcium\/calmodulin-dependent protein kinase IV: a multifunctional enzyme and potential therapeutic target","volume":"121","author":"Naz","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.130146_bb0350","doi-asserted-by":"crossref","first-page":"13937","DOI":"10.1074\/jbc.272.21.13937","article-title":"Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression","volume":"272","author":"Radeva","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.ijbiomac.2024.130146_bb0355","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1038\/sj.onc.1203640","article-title":"Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-\u03b21 stimulation","volume":"19","author":"Janji","year":"2000","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0360","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1074\/jbc.273.1.528","article-title":"Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity","volume":"273","author":"Wu","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130146_bb0365","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/157489209787002524","article-title":"The anti-cancer activity of noscapine: a review","volume":"4","author":"Mahmoudian","year":"2009","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.130146_bb0370","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00280-010-1356-3","article-title":"Noscapine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo","volume":"67","author":"Liu","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.130146_bb0375","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1080\/07391102.2020.1785945","article-title":"Rational design of 9-vinyl-phenyl noscapine as potent tubulin binding anti-cancer agent and evaluation of the effects of its combination on docetaxel","volume":"39","author":"Dash","year":"2021","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130146_bb0380","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3892\/ijo.2016.3476","article-title":"Apoptotic effect of noscapine in breast cancer cell lines","volume":"48","author":"Quisbert-Valenzuela","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130146_bb0385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2010.06.002","article-title":"Anti-cancer activity of noscapine, an opioid alkaloid in combination with cisplatin in human non-small cell lung cancer","volume":"71","author":"Chougule","year":"2011","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130146_bb0390","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/molecules22020250","article-title":"Emerging cytotoxic alkaloids in the battle against cancer: overview of molecular mechanisms","volume":"22","author":"Habli","year":"2017","journal-title":"Molecules"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024009498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024009498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:16:24Z","timestamp":1739942184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024009498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":78,"alternative-id":["S0141813024009498"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130146","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the promising potential of noscapine for cancer and neurodegenerative disease therapy through inhibition of integrin-linked kinase-1","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"130146"}}